- ►diabetesjournals.org S Dalle, G Fontés, AD Lajoix, L LeBrigand, R … - Diabetes, 2002 - Am Diabetes Assoc Miniglucagon, the COOH-terminal (19-29) fragment processed from glucagon, is a
potent and efficient inhibitor of insulin secretion from the MIN 6 ß-cell line.
Using the rat isolated-perfused pancreas, we investigated the inhibitory ... Cited by 17 - Related articles - BL Direct - All 4 versions
- ►jbc.org S Dalle, P Smith, P Blache, D Le-Nguyen, L Le … - Journal of Biological Chemistry, 1999 - ASBMB Using the MIN6 B-cell line, we investigated the hypothesis that miniglucagon,
the C-terminal (19-29) fragment processed from glucagon and present in
pancreatic A cells, modulates insulin release, and we analyzed its cellular ... Cited by 30 - Related articles - BL Direct - All 5 versions
D Bataille - Handbook of experimental pharmacology, 1996 - cat.inist.fr Preproglucagon and its processing. D BATAILLE Handbook of experimental
pharmacology 123, 31-51, Springer, 1996. Proglucagon; Proglucagon ... Cited by 14 - Related articles - BL Direct
S Dalle, G Fontés, AD Lajoix, L Le Brigand, … - Diabetes, 2002 - Am Diabetes Assoc Miniglucagon, the COOH-terminal (19-29) fragment processed from glucagon, is a
potent and efficient inhib- itor of insulin secretion from the MIN 6 -cell line.
Using the rat isolated-perfused pancreas, we investi- gated the inhibitory ... Related articles - All 3 versions
S Dalle, C Longuet, S Costes, C Broca, O … - Journal of Biological Chemistry, 2004 - ASBMB Page 1. 1 Glucagon promotes CREB phosphorylation via activation of ERK1/2
(extracellular signal-related kinase 1/2) in MIN6 cell line ... Cited by 2 - Related articles - All 2 versions
C Pavoine, V Brechler, A Kervran, P Blache, D … - American Journal of Physiology- Cell Physiology, 1991 - Am Physiological Soc Page 1. Miniglucagon [ glucagon- (19-29)] is a component of the positive inotropic
effect of glucagon CATHERINE PAVOINE, VERONIQUE BRECHLER, ALAIN KERVRAN, ... Cited by 16 - Related articles - All 3 versions
D Bataille - Handbook of experimental pharmacology, 1996 - cat.inist.fr Oxyntomodulin and its related peptides. D BATAILLE Handbook of experimental
pharmacology 123, 326-340, Springer, 1996. Peptide; Peptides ... Cited by 10 - Related articles - BL Direct
K Kawai, C Yokota, S Ohashi, Y Watanabe, K … - Diabetologia, 1995 - Springer Summary Since glucagon-like peptide-1 (7-36) amide (7-37) (GLP-1) has been found
to be a potent insu- linotropic hormone, it has been postulated that gluca- gon
stimulates insulin secretion from islet beta cells through the GLP-1 ... Cited by 30 - Related articles - BL Direct - All 3 versions
K Moens, V Berger, JM Ahn, C Van … - Diabetes, 2002 - Am Diabetes Assoc Glucagon is a potent stimulator of insulin release in the presence of a
permissive glucose concentration, activating β-cells in vitro via both
glucagon- and glucagon-like peptide-1 (GLP-1)-receptors. It is still ... Cited by 20 - Related articles - BL Direct - All 5 versions
P Blache, A Kervran, M Dufour, J Martinez, D … - The Journal of biological chemistry(Print), 1990 - cat.inist.fr GLUCAGON-(19-29), A CA 2+ PUMP INHIBITORY PEPTIDE, IS PROCESSED FROM GLUCAGON
IN THE RAT LIVER PLASMA MEMBRANE BY A THIOL ENDOPEPTIDASE. ... Cited by 8 - Related articles
